Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate…

By M. F. W. James Morris, MD Frcpc Scott Tyldesley, Mbbs Mrcp Frcr Sree Rodda, MD Frcpc Ross Halperin, MD Frcpc Howard Pai, MD Frcpc Michael McKenzie, MB ChB Frcpc Graeme Duncan, MB Mrcpi Frcpc Ffrrcsi Gerard Morton, Msc Jeremy Hamm, MD Frcpc Nevin Murray. International Journal of Radiation Oncology, Biology, Physics, 2017

674 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Radiation

View Paper: https://www.semanticscholar.org/paper/aefcef51694e7120d76ed627aa11d1c5bc323aba

Citations in the corpus

• EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. (2024, neutral): “In patients with localised high-risk PCa, dose-escalated IMRT, possibly including the pelvic lymphatics [121], and/ or a brachytherapy (BT) boost is an option [122].”